source
- Medicaid coverage for GLP-1 weight-loss drugs stalls, only Indiana signs onPresident Trump pledged to broaden Medicaid access to costly GLP-1 obesity medications by letting states negotiate prices directly with manufacturers. The rollout depended on state participation,…
- FDA signals upcoming rules for generative AI use in drug developmentThe FDA announced it intends to create regulatory guidance for the use of generative artificial intelligence in pharmaceutical research and development. The move follows growing interest in AI too…